Case report: Watch-and-wait strategy in resectable esophageal cancer following neoadjuvant chemoimmunotherapy: a case series

Case report: Watch-and-wait strategy in resectable esophageal cancer following neoadjuvant chemoimmunotherapy: a case series

Neoadjuvant chemoimmunotherapy (NCIT) has improved pathological complete response and conferred survival benefits in patients with locally advanced esophageal cancer. However, surgical complications unrelated to the tumor continue to detract from patient outcomes. While the “watch-and-wait” strategy...

Full description

Saved in:

Bibliographic Details
Main Authors:	Lingyu Tan, Guozhen Yang, Chufeng Zeng, Xu Zhang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-01-01
Series:	Frontiers in Immunology
Subjects:	neoadjuvant chemoimmunotherapy watch and wait esophageal cancer clinical complete response PD-1 blockade
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1502206/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

CT-based habitat radiomics for predicting treatment response to neoadjuvant chemoimmunotherapy in esophageal cancer patients
by: Weibo Kong, et al.
Published: (2024-12-01)

Comparison of single-port inflatable mediastinoscopic esophagectomy and thoracoscopic esophagectomy in patients with esophageal squamous cell carcinoma after neoadjuvant chemoimmunotherapy
by: Kaishang Zhang, et al.
Published: (2025-07-01)

Cost-effectiveness of watchful waiting versus immediate emergency department transfer after epinephrine autoinjector use in Canada
by: Yiwei Yin, et al.
Published: (2025-01-01)

Clinical efficacy and biomarkers of neoadjuvant chemoimmunotherapy in locally advanced esophageal squamous cell carcinoma
by: Siyou Deng, et al.
Published: (2025-06-01)

Comparative study of neoadjuvant chemoradiotherapy, chemotherapy, and chemoimmunotherapy for locally advanced esophageal squamous cell carcinoma
by: Likun Liu, et al.
Published: (2025-08-01)

Is adjuvant immunotherapy necessary after neoadjuvant chemoimmunotherapy in patients with resectable stage III NSCLC? A two-center real-world study
by: Song Guan, et al.
Published: (2025-07-01)

“Watch and wait” approach in the treatment of advanced radioiodine refractory differentiated thyroid cancer: a study of barriers and drivers of use
by: E. V. Borodavina, et al.
Published: (2024-04-01)

The prognostic power of major pathological response in esophageal squamous cell carcinoma patients undergoing neoadjuvant chemoimmunotherapy: a multi-center cohort study
by: Shuhan Xie, et al.
Published: (2025-07-01)

A Case of Local Resection of Secondary Perianal Paget Disease Appearing during “Watch and Wait” Management of Locally Advanced Rectal Cancer after Preoperative Chemoradiotherapy
by: Takahiro Amano, et al.
Published: (2025-07-01)

Intratumoral microbiota-aided fusion radiomics model for predicting tumor response to neoadjuvant chemoimmunotherapy in triple-negative breast cancer
by: Yilin Chen, et al.
Published: (2025-03-01)

Neoadjuvant chemoimmunotherapy for locally advanced squamous cell carcinoma of the head and neck: Systematic review and meta-analysis
by: Xiayi Zhu, et al.
Published: (2025-02-01)

Application of machine learning based on habitat imaging and vision transformer to predict treatment response of locally advanced esophageal squamous cell carcinoma following neoadjuvant chemoimmunotherapy: a multi-center study
by: Shu-Han Xie, et al.
Published: (2025-08-01)

Prognostic Impact of Adjuvant Immunotherapy in Patients With Resectable NSCLC After Neoadjuvant Chemoimmunotherapy: A Brief Report
by: Yichen Dong, MD, et al.
Published: (2025-01-01)

Exploring innovative models of surgical treatment for rectal cancer
by: LI Xinxiang, LUO Dakui
Published: (2025-07-01)

Watch-and-wait strategy in patients with objective response after immuno-chemotherapy for locally recurrent nasopharyngeal carcinoma: a pilot study
by: Quxia Zhang, et al.
Published: (2025-08-01)

Impact of Tregs on tumor regression in locally advanced G/GEJ cancer patients undergoing neoadjuvant chemoimmunotherapy
by: Yong Zhang, et al.
Published: (2025-08-01)

Prediction of pathological complete response to neoadjuvant chemoimmunotherapy in non–small cell lung cancer using 18F-FDG PET radiomics features of primary tumour and lymph nodes
by: Xingbiao Liu, et al.
Published: (2025-03-01)

Four-year follow-up from the phase 2 study TD-NICE: neoadjuvant treatment of tislelizumab combined with chemotherapy in resectable esophageal squamous cell carcinoma
by: Yajie Mao, et al.
Published: (2025-08-01)

Implementation of Organ Preservation for Locally Advanced Rectal Cancer in Canada: A National Survey of Clinical Practice
by: Megan Delisle, et al.
Published: (2025-06-01)

Neoadjuvant chemoimmunotherapy for small cell carcinoma of the esophagus: Clinical efficacy and biomarker exploration
by: Junhan Wu, et al.
Published: (2024-12-01)

MRI-based texture analysis for the evaluation of the response to neoadjuvant chemoimmunotherapy in locally advanced head and neck squamous cell carcinoma
by: Haoran Wei, et al.
Published: (2025-07-01)

A management of patients achieving clinical complete response after neoadjuvant therapy and perspectives: on locally advanced rectal cancer
by: Yu-Xin Liu, et al.
Published: (2025-01-01)

Clinical outcomes of conversion surgery following neoadjuvant chemoimmunotherapy in potentially resectable stage IIIA/IIIB non-small cell lung
by: Yana Qi, et al.
Published: (2025-05-01)

Organ preservation strategies for rectal cancer treatment: tarts or trap?
by: ZHOU Yihang, ZENG Ziwei, KANG Liang
Published: (2024-09-01)

Comparative Efficacy of PD‐1 Inhibitor‐Based Neoadjuvant Chemoimmunotherapy Regimens for Resectable Stage II–IIIa NSCLC: A Real‐World Retrospective Study
by: Bo Yan, et al.
Published: (2025-07-01)

Complete pathological remission and tertiary lymphoid structures are associated with the efficacy of resectable NSCLC receiving neoadjuvant chemoimmunotherapy: A double-center retrospective study
by: Ying Liu, et al.
Published: (2023-12-01)

Prognostic Significance, Radiological, and Metabolic Characteristics of Metastatic Lymph Nodes in Resectable Non‐Small Cell Lung Cancer Following Neoadjuvant Chemoimmunotherapy
by: Tianxiao Han, et al.
Published: (2025-05-01)

Mature tertiary lymphoid structures linked to HPV status and anti-PD-1 based chemoimmunotherapy response in head and neck squamous cell carcinoma
by: Lizao Zhang, et al.
Published: (2025-12-01)

Factors influencing pathological complete response following neoadjuvant chemoimmunotherapy in locally advanced microsatellite stable colorectal cancer: a retrospective analysis
by: Mingxiang Liu, et al.
Published: (2025-06-01)

Pathological complete response and prognostic predictive factors of neoadjuvant chemoimmunotherapy in early stage triple-negative breast cancer
by: Xuwei Chen, et al.
Published: (2025-05-01)

Analysis of the safety and efficacy of PD-1/PD-L1 inhibitors combined with chemotherapy in the treatment of locally advanced resectable esophageal squamous cell carcinoma: a systematic review and meta-analysis based on four randomized controlled trials
by: Tao Luo, et al.
Published: (2025-08-01)

Single-cell and spatial transcriptomic analyses revealing tumor microenvironment remodeling after neoadjuvant chemoimmunotherapy in non-small cell lung cancer
by: Xiaolu Cui, et al.
Published: (2025-04-01)

Predictive factors of pathological complete response after neoadjuvant therapy for locally advanced rectal cancer
by: LI Hao, LUO Yang, WANG Tingfeng, LIN Haiping, GONG Tingyue, ZHAO Yongheng, ZHONG Ming
Published: (2025-01-01)

Watchful waiting is an acceptable treatment option for asymptomatic primary ocular adnexal mucosa‐associated lymphoid tissue lymphoma: A retrospective study
by: Kentaro Mizuhara, et al.
Published: (2023-02-01)

Enhancing clinical complete response assessment in rectal cancer: integrating transanal multipoint full-layer puncture biopsy criteria: a systematic review
by: Xin Liu, et al.
Published: (2024-12-01)

Neoadjuvant chemoimmunotherapy versus neoadjuvant chemoradiotherapy in patients with borderline resectable esophageal squamous cell carcinoma
by: Jun-Peng Lin, et al.
Published: (2025-08-01)

Nonoperative management of rectal cancer
by: Hannah Williams, et al.
Published: (2024-12-01)

Total neoadjuvant immunochemotherapy for proficient mismatch repair or microsatellite stable locally advanced rectal cancer
by: Xing Li, et al.
Published: (2025-06-01)

ATF3 Within the Interferon Signaling Pathway: A Potential Biomarker for Predicting Pathological Response to Neoadjuvant Chemoimmunotherapy
by: Chao He, et al.
Published: (2025-04-01)

Surgical treatment outcomes in patients with non-small cell lung cancer treated with neoadjuvant systemic therapy. A pilot single-center retrospective study
by: A. V. Levitskiy, et al.
Published: (2025-05-01)